
David B. Frederiksen
Examiner (ID: 2809, Phone: (571)272-8152 , Office: P/2867 )
| Most Active Art Unit | 2867 |
| Art Unit(s) | 2858, 2867 |
| Total Applications | 600 |
| Issued Applications | 490 |
| Pending Applications | 57 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18626511
[patent_doc_number] => 20230285297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHODS OF PREPARING LIPID NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/792554
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792554 | METHODS OF PREPARING LIPID NANOPARTICLES | Jan 28, 2021 | Pending |
Array
(
[id] => 17946279
[patent_doc_number] => 20220333296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => NATURAL ANTIMICROBIAL FINISH ON FABRICS AND METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/753567
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753567
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/753567 | NATURAL ANTIMICROBIAL FINISH ON FABRICS AND METHOD THEREOF | Jan 24, 2021 | Abandoned |
Array
(
[id] => 18265103
[patent_doc_number] => 20230086345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => NOVEL METHOD OF ENHANCED DRUG DELIVERY TO THE NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/794934
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794934
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794934 | NOVEL METHOD OF ENHANCED DRUG DELIVERY TO THE NERVOUS SYSTEM | Jan 21, 2021 | Pending |
Array
(
[id] => 18196551
[patent_doc_number] => 20230050070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => Antimicrobial Composition
[patent_app_type] => utility
[patent_app_number] => 17/783814
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783814
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/783814 | Antimicrobial Composition | Dec 8, 2020 | Abandoned |
Array
(
[id] => 18108178
[patent_doc_number] => 20230001058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => DRUG-LOADED IMPLANTED MEDICAL DEVICE AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/779963
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779963 | DRUG-LOADED IMPLANTED MEDICAL DEVICE AND PREPARATION METHOD THEREFOR | Nov 24, 2020 | Pending |
Array
(
[id] => 18003411
[patent_doc_number] => 20220362177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => CERAMIDE RATIOS AS PREDICTIVE AND THERAPEUTIC BIOMARKERS FOR LEUKEMIAS
[patent_app_type] => utility
[patent_app_number] => 17/769907
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769907
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769907 | CERAMIDE RATIOS AS PREDICTIVE AND THERAPEUTIC BIOMARKERS FOR LEUKEMIAS | Oct 15, 2020 | Pending |
Array
(
[id] => 18034721
[patent_doc_number] => 20220378936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => DELIVERY SYSTEM COMPLEXES COMPRISING A PRECIPITATE OF AN ACTIVE AGENT AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/767816
[patent_app_country] => US
[patent_app_date] => 2020-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -55
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767816 | DELIVERY SYSTEM COMPLEXES COMPRISING A PRECIPITATE OF AN ACTIVE AGENT AND METHODS OF USE | Oct 12, 2020 | Pending |
Array
(
[id] => 17426662
[patent_doc_number] => 20220054370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => MULTILAYERED CATIONIC LIPOSOME FOR ENHANCING SKIN ABSORPTION AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/422803
[patent_app_country] => US
[patent_app_date] => 2020-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422803
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422803 | MULTILAYERED CATIONIC LIPOSOME FOR ENHANCING SKIN ABSORPTION AND PREPARATION METHOD THEREFOR | Sep 21, 2020 | Abandoned |
Array
(
[id] => 17988742
[patent_doc_number] => 20220354779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => NANOFIBER- AND NANOWHISKER-BASED TRANSFECTION PLATFORMS
[patent_app_type] => utility
[patent_app_number] => 17/753890
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753890
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/753890 | NANOFIBER- AND NANOWHISKER-BASED TRANSFECTION PLATFORMS | Sep 20, 2020 | Pending |
Array
(
[id] => 18075762
[patent_doc_number] => 20220401374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPOSITIONS AND METHODS FOR CANCER TREATMENT BY ENHANCING ANTITUMOR IMMUNITY USING TANNIC ACID-BASED NANOCAPSULES
[patent_app_type] => utility
[patent_app_number] => 17/641124
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641124
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641124 | COMPOSITIONS AND METHODS FOR CANCER TREATMENT BY ENHANCING ANTITUMOR IMMUNITY USING TANNIC ACID-BASED NANOCAPSULES | Sep 10, 2020 | Pending |
Array
(
[id] => 19111107
[patent_doc_number] => 20240122857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => PHARMACEUTICAL FORMULATIONS OF INDOLEAMINE 2, 3-DIOXYGENASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/753657
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/753657 | PHARMACEUTICAL FORMULATIONS OF INDOLEAMINE 2, 3-DIOXYGENASE INHIBITORS | Sep 9, 2020 | Pending |
Array
(
[id] => 17958689
[patent_doc_number] => 20220339269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => PANCREATIN MICROCAPSULES
[patent_app_type] => utility
[patent_app_number] => 17/640918
[patent_app_country] => US
[patent_app_date] => 2020-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17640918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/640918 | PANCREATIN MICROCAPSULES | Sep 2, 2020 | Pending |
Array
(
[id] => 17988076
[patent_doc_number] => 20220354113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => FUMIGANT FORMULATION FOR DRIP APPLICATION
[patent_app_type] => utility
[patent_app_number] => 17/638495
[patent_app_country] => US
[patent_app_date] => 2020-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5978
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638495 | FUMIGANT FORMULATION FOR DRIP APPLICATION | Aug 23, 2020 | Pending |
Array
(
[id] => 17836240
[patent_doc_number] => 20220273545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => COSMETIC
[patent_app_type] => utility
[patent_app_number] => 17/632131
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632131 | COSMETIC | Aug 18, 2020 | Pending |
Array
(
[id] => 17865246
[patent_doc_number] => 20220287981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => ADHESIVE DRUG DELIVERY MICROPARTICLES AND A PRODUCT COMPRISING THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/635390
[patent_app_country] => US
[patent_app_date] => 2020-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3332
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635390
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/635390 | ADHESIVE DRUG DELIVERY MICROPARTICLES AND A PRODUCT COMPRISING THEREOF | Aug 15, 2020 | Pending |
Array
(
[id] => 17828245
[patent_doc_number] => 20220265549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE
[patent_app_type] => utility
[patent_app_number] => 17/632891
[patent_app_country] => US
[patent_app_date] => 2020-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632891
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632891 | PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE | Aug 11, 2020 | Pending |
Array
(
[id] => 17828375
[patent_doc_number] => 20220265679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => PROLIPOSOMAL TESTOSTERONE UNDECANOATE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/631525
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631525
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631525 | PROLIPOSOMAL TESTOSTERONE UNDECANOATE FORMULATIONS | Aug 9, 2020 | Issued |
Array
(
[id] => 17790290
[patent_doc_number] => 20220249381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => COMPRESSED MACITENTAN COMPOSITIONS, METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/622305
[patent_app_country] => US
[patent_app_date] => 2020-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622305
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622305 | COMPRESSED MACITENTAN COMPOSITIONS, METHODS AND USES THEREOF | Jul 2, 2020 | Pending |
Array
(
[id] => 17368164
[patent_doc_number] => 20220023216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => INSTANTLY SOLUBLE PARTICLE AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/426864
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426864
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/426864 | INSTANTLY SOLUBLE PARTICLE AND METHOD FOR PRODUCING THE SAME | Jun 24, 2020 | Abandoned |
Array
(
[id] => 17790442
[patent_doc_number] => 20220249533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => COMPOSITIONS AND METHODS FOR BONE REPAIR AND BONE HEALTH
[patent_app_type] => utility
[patent_app_number] => 17/616499
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616499
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616499 | COMPOSITIONS AND METHODS FOR BONE REPAIR AND BONE HEALTH | Jun 2, 2020 | Pending |